Guifeng Su
Impact in
-
- Antimicrobial Peptides and Activities
-
- Ubiquitin and proteasome pathways
- Biological Activity of Diterpenoids and Biflavonoids
- Heat shock proteins research
Papers in
-
- Cancer-related gene regulation 3
- Wnt/β-catenin signaling in development and cancer 3
- Hedgehog Signaling Pathway Studies 2
- ATP Synthase and ATPases Research 2
- Epigenetics and DNA Methylation 2
-
- Herpesvirus Infections and Treatments 2
- Co-authors
- Yifei Wang (8 shared papers)Jiaoyan Jia (2 shared papers)Kai Zheng (2 shared papers)Yiliang Wang (2 shared papers)Lianzhou Huang (2 shared papers)Yuan Wang (2 shared papers)Feng Li (2 shared papers)Lingmei Kong (6 shared papers)
In The Last Decade
Guifeng Su
16 papers receiving 304 citations
Peers
Comparison fields: 5 of 64
- Microbiology 23
- Molecular Biology 178
- Cancer Research 30
- Pharmacology 18
- Complementary and alternative medicine 14
Countries citing papers authored by Guifeng Su
This map shows the geographic impact of Guifeng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guifeng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guifeng Su more than expected).
Fields of papers citing papers by Guifeng Su
This network shows the impact of papers produced by Guifeng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guifeng Su. The network helps show where Guifeng Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Guifeng Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 64 | |
| 2 | 2021 | 36 | |
| 3 | 2019 | 34 | |
| 4 | 2019 | 31 | |
| 5 | 2021 | 27 | |
| 6 | 2017 | 27 | |
| 7 | 2021 | 25 | |
| 8 | 2020 | 15 | |
| 9 | 2023 | 15 | |
| 10 | 2022 | 10 | |
| 11 | 2019 | 6 | |
| 12 | 2024 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2024 | 2 | |
| 16 | 2021 | 1 |
About Guifeng Su
Guifeng Su is a scholar working on Molecular Biology, Epidemiology, Oncology, Pharmacology and Cellular and Molecular Neuroscience, having authored 16 papers that have together received 306 indexed citations. Recurring topics across this work include Cancer-related gene regulation (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Herpesvirus Infections and Treatments (2 papers), Hedgehog Signaling Pathway Studies (2 papers), ATP Synthase and ATPases Research (2 papers), Epigenetics and DNA Methylation (2 papers) and Berberine and alkaloids research (2 papers). The work is most often cited by research in Microbiology (23 citations), Molecular Biology (178 citations), Cancer Research (30 citations), Pharmacology (18 citations) and Complementary and alternative medicine (14 citations). Guifeng Su has collaborated with scholars based in China, Japan and Canada. Frequent co-authors include Yifei Wang, Jiaoyan Jia, Kai Zheng, Yiliang Wang, Lianzhou Huang, Yuan Wang, Feng Li, Lingmei Kong, Qihong Yang and Yiying Zhu. Their work appears in journals such as Biochemical and Biophysical Research Communications, Oncotarget, European Journal of Pharmacology, Biochemical Pharmacology and Frontiers in Cellular and Infection Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.